Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

9.46
Delayed Data
As of 4:00pm ET
 -0.29 / -2.97%
Today’s Change
9.10
Today|||52-Week Range
9.99
--
Year-to-Date
Opko Health Inc (OPK) CEO & Chairman, 10% Owner Phillip Frost Bought $169,560 of Sto...
4:32pm / GuruFocus News - Paid Partner Content
Why Sprint, Energy Transfer Equity, and Opko Health Jumped Today
Jun 21 / MotleyFool.com - Paid Partner Content
Opko Health Inc (OPK) CEO & Chairman, % Owner Phillip Frost Bought 69,56 of Stoc...
Jun 23 / GuruFocus News - Paid Partner Content
Here's Why Opko Health (OPK) Stock Is Gaining Today
Jun 21 / Zacks.com - Paid Partner Content
Weak On High Volume: Opko Health (OPK)
Jun 22 / TheStreet.com - Paid Partner Content
Company News for June 21, 2016
Jun 21 / Zacks.com - Paid Partner Content
Opko Health (OPK) Catches Eye: Stock Adds 5.6% in Session
Jun 22 / Zacks.com - Paid Partner Content
Opko (OPK) Stock Gains as FDA Approves Rayaldee
Jun 21 / TheStreet.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
Opko Health (OPK) Gets the Green Light for Rayaldee Drug
Jun 21 / Investing Channel - Paid Partner Content

Today’s Trading

Previous close9.75
Today’s open9.38
Day’s range9.30 - 9.58
Volume5,439,416
Average volume (3 months)--
Market cap$5.0B
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-5.55%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio--
Price/Sales9.97
Price/Book2.53

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-3.17-3.01%
SGENSeattle Genetics Inc-2.48-6.19%
ANACAnacor Pharmaceutica...0.000.00%
ACADACADIA Pharmaceutica...-2.07-6.18%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)$0.00
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Chart unavailable

Partner Offers

Search for Jobs